Research Fellow: Epidemiology / Biostatistics

Keele University

Contact:

Email address: k.mason@keele.ac.uk
Twitter: @KayleighJMason

Dr Kayleigh Mason

Community Member


Biography

During my undergraduate degree in Pharmacology at The University of Manchester, I completed an industrial placement year at GSK’s clinical trial unit at Addenbrooke’s Hospital in Cambridge. I worked on 2x phase IV post-marketing studies, 3x phase I studies investigating experimental pain models in healthy volunteers and 2x studies investigating pain mechanisms in patients with osteoarthritis. The experimental pain studies included the use of quantitative sensory testing. I used this methodology in my PhD to investigate associations between pain intensity, or changes in pain following treatment, and altered pain processing in people with knee pain and/or knee osteoarthritis. I completed my PhD with the (now) Centre for Epidemiology Versus Arthritis at The University of Manchester in 2014. The training I received in epidemiology during my PhD helped me to decide to pursue a career within this field.

In my first post-doc position, I worked on the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR) at The University of Manchester. BADBIR is a large pharmacovigilance cohort designed to collect data reflecting true clinical practice for treatment of patients with moderate-severe psoriasis with biologic, small molecule and conventional systemic therapies in the UK and ROI. My research investigated the safety, utilisation, and effectiveness of therapies prescribed for the treatment of moderate-severe psoriasis. My role included providing methodological support for researchers using the BADBIR dataset.

I joined Keele University in 2020 and currently work as a Research Fellow in Epidemiology / Biostatistics. I have gained experience in the acquisition, analysis and interpretation of electronic medical records from Clinical Practice Research Datalink (CPRD) Aurum, a national de-anonymised database of primary care records, and further developed my analytical and data management skills.

Since joining Keele, I have been Lead Analyst on a recently completed project investigating the impact of musculoskeletal pain on prognosis of other conditions using electronic health records from primary care, funded by Nuffield Foundation (MSKCOM Study). I am currently Lead Analyst for the quantitative work package on an NIHR programme grant investigating musculoskeletal pain in young people recorded in primary care (CAM-Pain Programme) and secured my first grant as PI to investigate the impact of mental health conditions and neurodiversity in those young people with musculoskeletal pain presenting to primary care (CLIMB Study).

Further details:

MSKCOM — https://www.keele.ac.uk/mskcom

CAM-Pain — https://www.nihr.ac.uk/documents/addressing-child-and-adolescent-musculoskeletal-pain-the-cam-pain-programme/31465

CLIMB — https://www.spcr.nihr.ac.uk/research/projects/the-2018climb2019-study

Additional HDR Midlands Team Members

Firoza Davies

Patient & Public Representative
East Midlands

Mr Colin Monckton

Director of Performance and Information
Nottingham University Hospitals NHS Trust

Rachel Caswell

Senior Healthcare Analyst
Midlands Analyst Network Lead Strategy Unit

Kathie McPeake

Macmillan Living with Cancer Programme Manager
NHS Lincolnshire Integrated Care Board